AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6513774 — intervention group
Group type: COMPARATOR
Intervention: Progressive incremental test (PI)
Number of subjects: 12
Study 6513774 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tests (6M-AO and PI)
Number of subjects: 12
Study 30112318 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational package
Number of subjects: 60
Study 27543533 — intervention group
Group type: EXPERIMENTAL
Intervention: PecS II block with ropivacaine 0.5%, 25 ml
Number of subjects: 40
Study 27543533 — intervention group
Group type: COMPARATOR
Intervention: TPVB with ropivacaine 0.5%, 25 ml
Number of subjects: 40
Study 27543533 — intervention group
Group type: EXPERIMENTAL
Intervention: PecS II block
Number of subjects: 40
Study 27543533 — intervention group
Group type: COMPARATOR
Intervention: TPVB
Number of subjects: 40
Study 24450857 — intervention group
Group type: EXPERIMENTAL
Intervention: Idelalisib (150 mg) plus rituximab
Number of subjects: 220
Study 24450857 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab plus Idelalisib
Number of subjects: 220
Study 24450857 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus rituximab
Number of subjects: 220
Study 24450857 — intervention group
Group type: EXPERIMENTAL
Intervention: Idelalisib plus rituximab
Number of subjects: 220
Study 22847288 — intervention group
Group type: EXPERIMENTAL
Intervention: Music group (n = 83) listened to music 7 times for 30 minutes during the first 3 postoperative days
Number of subjects: 168
Study 22847288 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 85) did not listen to music
Number of subjects: 168
Study 22847288 — intervention group
Group type: EXPERIMENTAL
Intervention: Music group (n = 83)
Number of subjects: 168
Study 20339099 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/day (LOS)
Number of subjects: 0
Study 20339099 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/day (LOS) plus Hydrochlorothiazide 25 mg/day (LOS/HCT)
Number of subjects: 0
Study 20339099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18657671 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol (S) 167 ± 66 mg/d
Number of subjects: 135
Study 18657671 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers (BB) 62 ± 26 mg/d for atenolol and 104 ± 47 mg/d for metoprolol
Number of subjects: 135
Study 18657671 — intervention group
Group type: COMPARATOR
Intervention: Both Sotalol and Beta-blockers
Number of subjects: 135
Study 15668282 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoendocrine therapy (2MT or 3MT)
Number of subjects: 309
Study 15668282 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant treatment (8 cycles of mitoxantrone, methotrexate with tamoxifen)
Number of subjects: 309
Study 14511555 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone-proguanil (AP)
Number of subjects: 39
Study 14511555 — intervention group
Group type: COMPARATOR
Intervention: Control group (mefloquine-artesunate)
Number of subjects: 39
Study 12362076 — intervention group
Group type: EXPERIMENTAL
Intervention: New reference plane for HRT defined by OCT measurements
Number of subjects: 50
Study 9989680 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted diet with conventional foods (group A)
Number of subjects: 100
Study 9989680 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted diet with meal replacements (group B)
Number of subjects: 100
Study 9989680 — intervention group
Group type: COMPARATOR
Intervention: Both groups during phase 2
Number of subjects: 100
Study 7780274 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional perimetry
Number of subjects: 368
Study 7780274 — intervention group
Group type: EXPERIMENTAL
Intervention: White-noise field campimetry
Number of subjects: 368
Study 2082307 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 122
Study 2082307 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 122
Study 2082307 — intervention group
Group type: COMPARATOR
Intervention: Morphine 2 mg
Number of subjects: 122
Study 2082307 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 4 mg
Number of subjects: 122
Study 7369170 — intervention group
Group type: COMPARATOR
Intervention: 8 mg/kg caffeine
Number of subjects: 8
Study 7369170 — intervention group
Group type: COMPARATOR
Intervention: 4 mg/kg coffee
Number of subjects: 8
Study 7369170 — intervention group
Group type: COMPARATOR
Intervention: Coffee with a 3080 kJ meal
Number of subjects: 8
Study 31710995 — intervention group
Group type: EXPERIMENTAL
Intervention: Total metabolic tumor volume (TMTV) with SUV41max thresholding method
Number of subjects: 510
Study 31710995 — intervention group
Group type: EXPERIMENTAL
Intervention: Total metabolic tumor volume (TMTV) with SUV4 thresholding method
Number of subjects: 510
Study 31710995 — intervention group
Group type: EXPERIMENTAL
Intervention: Interim positron emission tomography (iPET) response with 66% SUVmax reduction
Number of subjects: 510
Study 31387160 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrant positioning method
Number of subjects: 72
Study 31387160 — intervention group
Group type: COMPARATOR
Intervention: Traditional screw positioning method
Number of subjects: 72
Study 27530980 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror-based tactile and motor training
Number of subjects: 6
Study 27530980 — intervention group
Group type: COMPARATOR
Intervention: Bimanual therapy (standard practice)
Number of subjects: 6
Study 25884824 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone application (SIMPLe) on top of treatment as usual
Number of subjects: 0
Study 25884824 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual alone
Number of subjects: 0
Study 23550962 — intervention group
Group type: EXPERIMENTAL
Intervention: Abusive father-son relationship
Number of subjects: 121
Study 23550962 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantity of alcohol consumption
Number of subjects: 121
Study 21557114 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.24 mg/kg for ED50, 0.33 mg/kg for ED95)
Number of subjects: 54
Study 21557114 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 54
Study 19724042 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral LUNA
Number of subjects: 487
Study 19724042 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopy without pelvic denervation (no LUNA)
Number of subjects: 487
Study 17724363 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg i.v. pantoprazole infused for 2 minutes
Number of subjects: 48
Study 17724363 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg i.v. pantoprazole infused for 15 minutes
Number of subjects: 48
Study 17724363 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS) for pain and burning
Number of subjects: 48
Study 17724363 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 48
Study 15203777 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 US dollars incentive
Number of subjects: 300
Study 15203777 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 US dollars incentive
Number of subjects: 300
Study 15203777 — intervention group
Group type: EXPERIMENTAL
Intervention: 0 US dollars incentive
Number of subjects: 300
Study 15203777 — intervention group
Group type: COMPARATOR
Intervention: Control group (no monetary incentive)
Number of subjects: 300
Study 15203777 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 300
Study 15203777 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 300
Study 15203777 — intervention group
Group type: EXPERIMENTAL
Intervention: Median DNA yield
Number of subjects: 300
Study 15203777 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR amplification potential
Number of subjects: 300
Study 11157022 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified treatment (ICE every 2 weeks with filgrastim and autologous blood reinfusion)
Number of subjects: 50
Study 11157022 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (ICE every 4 weeks)
Number of subjects: 50
Study 9778080 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bolus alteplase (two 50 mg bolus injections 30 minutes apart)
Number of subjects: 461
Study 9778080 — intervention group
Group type: COMPARATOR
Intervention: Front-loaded alteplase infusion (100 mg total: 15 mg bolus, then 50 mg over 30 minutes, then 35 mg over 60 minutes)
Number of subjects: 461
Study 8158717 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-acid neutralizing stress ulcer prophylaxis (SUC)
Number of subjects: 96
Study 8158717 — intervention group
Group type: COMPARATOR
Intervention: Acid neutralizing prophylaxis (AN)
Number of subjects: 96
Study 3219313 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protein intake at 8.6% of energy
Number of subjects: 8
Study 3219313 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protein intake at 11.5% of energy
Number of subjects: 8
Study 3219313 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protein intake at 14.0% of energy
Number of subjects: 8
Study 3219313 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 4 of the study period
Number of subjects: 8
Study 3219313 — intervention group
Group type: COMPARATOR
Intervention: Overall analysis
Number of subjects: 8
Study 30191357 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 39
Study 30191357 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 39
Study 30191357 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall DOAC usage
Number of subjects: 39
Study 27365387 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies to C. difficile toxins A and B (not detailed in dosage or duration)
Number of subjects: 0
Study 27365387 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 24056586 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced 6% HES (130/0.4, Volulyte)
Number of subjects: 202
Study 24056586 — intervention group
Group type: COMPARATOR
Intervention: Balanced crystalloid (Hartmann's solution)
Number of subjects: 202
Study 20558112 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological test battery before antiepileptic treatment
Number of subjects: 50
Study 20558112 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological test battery after a mean of 5 years
Number of subjects: 50
Study 18524643 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam sclerosant (3% polidocanol foam, 2-2.5 ml injected)
Number of subjects: 95
Study 18524643 — intervention group
Group type: COMPARATOR
Intervention: Liquid sclerosant (3% polidocanol liquid, 2-2.5 ml injected)
Number of subjects: 95
Study 15965198 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5-10 mg/day)
Number of subjects: 22
Study 15965198 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 15284372 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR) group with Slim-Fast products for 2 meals (1800 kJ) and a low-fat evening meal
Number of subjects: 66
Study 15284372 — intervention group
Group type: COMPARATOR
Intervention: Control (C) group following a low fat/energy diet with shopping vouchers
Number of subjects: 66
Study 15284372 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study 15284372 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal Replacement (MR) group
Number of subjects: 66
Study 10737167 — intervention group
Group type: COMPARATOR
Intervention: On-line HDF (HDF100)
Number of subjects: 16
Study 10737167 — intervention group
Group type: EXPERIMENTAL
Intervention: On-line HDF (HDF120)
Number of subjects: 16
Study 10737167 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term dialysis patients
Number of subjects: 16
Study 8649239 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-supplemented formula (0.2% docosahexaenoic acid)
Number of subjects: 0
Study 8649239 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (control group)
Number of subjects: 0
Study 1532615 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg twice daily
Number of subjects: 103
Study 1532615 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin 500 mg four times daily
Number of subjects: 103
Study 3924399 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-hydrogen divalproate (SHD) 250 mg
Number of subjects: 14
Study 3924399 — intervention group
Group type: COMPARATOR
Intervention: Sodium valproate 300 mg
Number of subjects: 14
Study 3069551 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg
Number of subjects: 20
Study 3069551 — intervention group
Group type: EXPERIMENTAL
Intervention: cimetidine 800 mg
Number of subjects: 20
Study 3069551 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 31729491 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients addicted to tobacco (group 1)
Number of subjects: 815
Study 31729491 — intervention group
Group type: COMPARATOR
Intervention: Patients who had never smoked (group 2)
Number of subjects: 815
Study 28266260 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational group interventions for children with parents suffering from cancer
Number of subjects: 0
Study 28266260 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational group interventions for cancer patients and their partners
Number of subjects: 0
Study 28266260 — intervention group
Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 0
Study 24448652 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole/sodium bicarbonate (Zegerid(®)) 40 mg once daily for 8 weeks (nighttime dosing)
Number of subjects: 92
Study 24448652 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole/sodium bicarbonate (Zegerid(®)) 40 mg once daily for 8 weeks (morning dosing)
Number of subjects: 92
Study 24070990 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (group songwriting intervention)
Number of subjects: 83
Study 24070990 — intervention group
Group type: EXPERIMENTAL
Intervention: Education (group-based condition)
Number of subjects: 83
Study 24070990 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 83
Study 21150583 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical muscle stimulation applied for 60 mins per day for 7 days.
Number of subjects: 8
Study 21150583 — intervention group
Group type: COMPARATOR
Intervention: Control thigh (non-stimulated muscle).
Number of subjects: 8
Study 21150583 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of stimulated vs non-stimulated thigh.
Number of subjects: 8
Study 19095028 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 0
Study 19095028 — intervention group
Group type: EXPERIMENTAL
Intervention: Live-attenuated influenza vaccine
Number of subjects: 0
Study 16501533 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% metronidazole gel
Number of subjects: 302
Study 16501533 — intervention group
Group type: COMPARATOR
Intervention: Placebo (KY Jelly)
Number of subjects: 302
Study 12387171 — intervention group
Group type: EXPERIMENTAL
Intervention: Premixed nitrous oxide and oxygen
Number of subjects: 80
Study 10189007 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone 450‐600 mg orally (PNF)
Number of subjects: 246
Study 10189007 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone 450‐600 mg orally plus digitalis 0.750‐1 mg i.v. (PNF+D)
Number of subjects: 246
Study 10189007 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitalis 0.75‐1 mg i.v. plus quinidine 1100 mg (D+Q)
Number of subjects: 246
Study 10189007 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 246
Study 7499668 — intervention group
Group type: EXPERIMENTAL
Intervention: PSR examination
Number of subjects: 24
Study 7499668 — intervention group
Group type: COMPARATOR
Intervention: Conventional periodontal examination
Number of subjects: 24
Study 2316591 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment for 1 day
Number of subjects: 6803
Study 2316591 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment for 3 days
Number of subjects: 6803
Study 2316591 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin treatment for 10 days
Number of subjects: 6803
Study 2316591 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalexin or nitrofurantoin therapy for 7 days (for amoxicillin-resistant infections)
Number of subjects: 6803
Study 2316591 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 6803
Study 453495 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexitone
Number of subjects: 0
Study 453495 — intervention group
Group type: COMPARATOR
Intervention: Etomidate
Number of subjects: 0
Study 453495 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexitone with fentanyl
Number of subjects: 0
Study 453495 — intervention group
Group type: COMPARATOR
Intervention: Etomidate with fentanyl
Number of subjects: 0
Study 31982170 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate 625mg orally three times a day for a week (treated group)
Number of subjects: 50
Study 31982170 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics (untreated group)
Number of subjects: 50
Study 29081332 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help manual with treatment rationale
Number of subjects: 69
Study 29081332 — intervention group
Group type: COMPARATOR
Intervention: Self-help manual with cognition rationale
Number of subjects: 69
Study 25345553 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 75
Study 25345553 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 75
Study 25345553 — intervention group
Group type: COMPARATOR
Intervention: Control group (community-dwelling older adults)
Number of subjects: 75
Study 25393311 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Care (PC)
Number of subjects: 221
Study 25393311 — intervention group
Group type: COMPARATOR
Intervention: Specialized Care (SC)
Number of subjects: 221
Study 24051496 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic mucosal resection (EMR)
Number of subjects: 128
Study 24051496 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EMR)
Number of subjects: 128
Study 20958183 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% voriconazole (VZ) single dose
Number of subjects: 119
Study 20958183 — intervention group
Group type: COMPARATOR
Intervention: 0.1% voriconazole (VZ) single dose
Number of subjects: 119
Study 20958183 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% voriconazole (VZ) multidose (hourly)
Number of subjects: 119
Study 20958183 — intervention group
Group type: COMPARATOR
Intervention: 1% voriconazole (VZ) multidose (bi-hourly)
Number of subjects: 119
Study 20958183 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstituted voriconazole formulations
Number of subjects: 119
Study 18228109 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 0
Study 18228109 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 0
Study 18228109 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 0
Study 18228109 — intervention group
Group type: COMPARATOR
Intervention: Cost-effectiveness analysis
Number of subjects: 0
Study 17014446 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump coronary artery bypass grafting (38 patients)
Number of subjects: 52
Study 17014446 — intervention group
Group type: COMPARATOR
Intervention: Off-pump coronary artery bypass grafting (14 patients)
Number of subjects: 52
Study 14613287 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 306
Study 14613287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 10391572 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ceftazidime
Number of subjects: 41
Study 10391572 — intervention group
Group type: COMPARATOR
Intervention: Oral ciprofloxacin
Number of subjects: 41
Study 10391572 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 41
Study 8694152 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled alfentanil infusion
Number of subjects: 20
Study 8694152 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled bolus administration of morphine
Number of subjects: 20
Study 1878233 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg of famotidine and 0.5 mg/kg of diazepam rectally 30 to 120 minutes before anesthesia induction (Group 2)
Number of subjects: 80
Study 1878233 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg/kg of diazepam rectally 30 to 120 minutes before anesthesia induction (Group 1)
Number of subjects: 80
Study 7060034 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, doxorubicin (Adriamycin), and prednisone (CAP)
Number of subjects: 65
Study 7060034 — intervention group
Group type: EXPERIMENTAL
Intervention: Carmustine (BCNU), doxorubicin, and prednisone (BAP)
Number of subjects: 65
Study 7060034 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective responders (both groups)
Number of subjects: 65
Study 30715732 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Universal Retreatment system followed by XP‐Endo Finisher file
Number of subjects: 30
Study 30715732 — intervention group
Group type: COMPARATOR
Intervention: ProTaper Universal Retreatment system
Number of subjects: 30
Study 30085138 — intervention group
Group type: EXPERIMENTAL
Intervention: PGT‐A by comprehensive chromosome screening (CCS) of the first and second polar body
Number of subjects: 396
Study 30085138 — intervention group
Group type: COMPARATOR
Intervention: ICSI without chromosome screening
Number of subjects: 396
Study 30085138 — intervention group
Group type: EXPERIMENTAL
Intervention: PGT‐A by CCS
Number of subjects: 396
Study 27538799 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar TURP (M-TURP)
Number of subjects: 81
Study 27538799 — intervention group
Group type: COMPARATOR
Intervention: Bipolar TURP (B-TURP)
Number of subjects: 81
Study 24893225 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategies designed to improve snacks served and increase moderate-to-vigorous physical activity (MVPA) in children attending ASPs.
Number of subjects: 1800